Skip to main content

Investing

By Jessica Hagen | 03:21 pm | April 24, 2024
Xaira's CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab's scientific papers.
By Trevor Dermody | 02:48 pm | April 24, 2024
Pediatric chronic care company Clarity Pediatrics also secured $10 million in seed funding and Los Angeles-based Handl Health brought in $2.5M.
By Jessica Hagen | 01:44 pm | April 22, 2024
The health technology company will use the funds to support the growth of its provider partnerships.
By Jessica Hagen | 03:03 pm | April 16, 2024
The funds will support the company's global growth and advance its AI-enabled Internet of Things platform.
By Jessica Hagen | 12:03 pm | April 16, 2024
The Series C equity and debt financing round brings the company's total raise to $103 million. Two Chairs will use it to expand its reach nationally.  
By Trevor Dermody | 04:51 pm | April 15, 2024
The company plans to use the funds to further its AI development and create new hybrid solutions.
By Trevor Dermody | 04:44 pm | April 12, 2024
The New York-based mental health company also announced a measurement-informed system to help providers transition to value-based care.
By Trevor Dermody | 05:08 pm | April 08, 2024
Stock exchange rules give Amwell six months to comply with its minimum price requirement of $1 per share or be delisted. Amwell last traded above $1 in March.
By Jessica Hagen | 06:10 pm | April 04, 2024
EarliTech Diagnostics secured $21.5 million, Manifold emerged with $15 million, and Beanstalk Benefits launched out of Redesign Health with $7.5 million.
By Adam Ang | 08:02 pm | April 03, 2024
It looks to use its fresh funds to secure the US FDA's approval for its AI software.